Search
Data
Total number of tested isolates* and resistance combinations among invasive isolates tested against aminopenicillins, third-generation cephalosporins, fluoroquinolones, aminoglycosides and carbapenems (n=52 788), EU/EEA countries, 2014
* Only data from isolates tested against all five antimicrobial groups were included in the analysis.
Data
Number of laboratories reporting isolates resistant to third-generation cephalosporins (3GCREC)
Number of laboratories reporting isolates resistant to third-generation cephalosporins (3GCREC), numbers of 3GCREC isolates identified and percentage of isolates positive for extended-spectrum beta-lactamase (ESBL), as ascertained by the participating laboratories, EU/EEA countries, 2014
Data
Total number of isolates tested (N) and percentage combined resistance to fluoroquinolones, third-generation cephalosporins and aminoglycosides (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2010-2013
Data
Total number of invasive isolates tested (N) and percentage resistant to aminoglycosides (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2011-2014
Data
Total number of invasive isolates tested (N) and percentage resistant to aminopenicillins (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2011-2014
Data
Total number of invasive isolates tested (N) and percentage resistant to carbapenems (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2011-2014
Data
Total number of invasive isolates tested (N) and percentage resistant to third-generation cephalosporins (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2011-2014
Data
Total number of invasive isolates tested (N) and percentage resistant to fluoroquinolones (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2011-2014
Data